Skip to main content

Anticancer potential of Phoenix dactylifera L. seed extract in human cancer cells and pro-apoptotic effects mediated through caspase-3 dependent pathway in human breast cancer MDA-MB-231 cells: an in vitro and in silico investigation



Phoenix dactylifera L. has a diverse set of pharmacological properties due to its distinct phytochemical profile. The purpose of this study was to investigate the anticancer potential of Phoenix dactylifera seed extract (PDSE) in human breast cancer MDA-MB-231 and MCF-7 cells, as well as liver cancer HepG2 cells, and to investigate the anticancer efficacy in triple-negative MDA-MB-231 cells, followed by in silico validation of the molecular interaction between active components of PDSE and caspase-3, an apoptosis executioner protein .


In this study, human cancer cell lines were cultured and subsequently treated with 10 to 100 μg/mL of PDSE. MTT test was performed to determine the cell viability, MMP was measured using fluorescent probe JC-1, nuclear condensation was determined by Hoechst 33258 dye, Annexin V-FITC & PI staining and cell cycle analysis were evaluated through flow cytometer, and apoptotic markers were detected using western blotting. The bioactive agents in PDSE were identified using high-performance liquid chromatography (HPLC) analysis. The binding affinity was validated using molecular docking tools AutoDock Vina and iGEMDOCK v2.1.


Cell viability data indicated that PDSE inhibited cell proliferation in both breast cancer cells and liver cancer cells. MDA-MB-231 cells showed maximum growth inhibition with an IC50 value of 85.86 μg/mL for PDSE. However, PDSE did not show any significant toxicity against the normal Vero cell line. PDSE induced MMP loss and formation of apoptotic bodies, enhanced late apoptosis at high doses and arrested cells in the S phase of cell cycle. PDSE activated the enzymatic activity of cleaved caspase-3 and caused the cleavage of poly-ADB ribose polymerase (PARP) protein. PDSE upregulated pro-apoptotic Bax protein markedly but  no significant effect on tumor suppressor protein p53, while it downregulated the anti-apoptotic Bcl-2 protein expression. HPLC analysis showed the presence of rutin and quercetin bioactive flavonols in ethanolic extract of PDS. Interestingly, both active components revealed a strong binding interaction with amino acid residues of caspase-3 (PDB ID: 2XYP; Hetero 4-mer - A2B2) protein.


PDS could serve as a potential medicinal source for apoptotic cell death in human breast cancer cells and, thus, could be used as a promising and crucial candidate in anticancer drug development. This study warrants further in vivo research, followed by clinical investigation.

Peer Review reports


Cancer is an ensemble of diseases that develop over a long stretch of time, causing millions of mortalities across the globe [1]. Owing to its extremely aggressive nature and poor prognosis and survival rate, cancer remains an important public health issue worldwide. Amongst various cancers, breast and liver cancer are of great concern globally, accounting for 2.26 and 2.21 million new cases, respectively in 2020 [2]. Recent cancer statistics have suggested a significant rise in the number of breast cancer patients, indicating breast cancer (11.7%), as a most prevalent type of cancer diagnosed every year, followed by lung (11.4%), colorectal (10.0%), prostate (7.3%), and stomach (5.6%) cancers [3]. As per the statistic, 1 out of 4 cancer patients are diagnosed with breast cancer, causing 1 out of 6 cancer related mortalities [4]. Among Indian females, breast cancer ranks as number one cancer, having a mortality rate of 12.7 per 100,000 women [5]. The incidence of liver and breast cancers has increased in many parts of the world, notably in India, North and South America, as well as in most European countries.

Natural products have emerged as a benchmark in the process of discovery and development of novel drugs, particularly for anticancer and anti-infectious agents [6]. It is noteworthy that about fifty percent of anti-cancer drugs and therapies are either derived from natural sources or natural products [7]. A range of herbal derived components such as alkaloids, polyphenols, flavonoids, terpenoids and polysaccharides are being used against various cancers and communicable diseases [8, 9]. Various therapeutic strategies and interventions are available for these diseases; however, most of them remain incurable because of drug resistance. In addition, some natural products are not free from side effects. Therefore, the search and discovery of novel plant-derived products are essential to improve the impact and outcome of plant-based therapeutic agents.

Ajwa dates are the fruits of the native tree Phoenix dactylifera L. of Saudi Arabia. For thousands of years in Egypt and the Middle East, the tree has been enlisted for its diverse medicinal uses in Pharmacopeia [10]. All parts of the plant, particularly fruits, seeds, leaves, flowers and roots, are utilized in Ayurveda-based formulations and have a significant role as a Rasayana i.e. rejuvenation medicine [11]. The therapeutic effects of date palm have been well-documented [12]. Ajwa dates are cultivated only in Saudi Arabia/Al-Madinah Al-Munawara and be effective against several types of diseases [13]. Ajwa date seeds have been utilized in Egyptian traditional medicine to treat a variety of infectious disorders diabetes and cancer [14, 15]. Traditionally and historically, Ajwa dates are used mainly for their antioxidant, anti-inflammatory and hepatoprotective, anticancer and cardiac function improvement effect [16, 17].

Primary breast cancer is confined to the milk glands or ducts of the breast. However, in some cases, primary breast cancer becomes aggressive and spreads to distant organs such as the liver causing metastasis [18]. Therefore, in the present study, cancer cell lines from two different tissues viz. breast (MDA-MB-231 and MCF-7), and liver (HepG2) have been used to investigate the anticancer potential of Phoenix dactylifera seed extract (PDSE). African green monkey normal kidney epithelial cell line (Vero) has been widely used in various toxicological, virology and pharmacological research domains, particularly as a sensitive model for toxicity assays of compounds of various nature, either chemical or microbial toxins [19,20,21,22]. Thus, to test the toxicity of PDSE, Vero cell line was used as a control to mimic normal mammalian cells. HPLC characterization was carried out to detect the presence of active phytoconstituents and rutin and quercetin were found in the extract. In silico computational analyses revealed that these active ingredients of PDSE displayed excellent binding interaction with caspase-3 protein. Thus, the present study indicates that PDSE might be utilized as an adjunct to the mainline of cancer treatment or be developed as a therapeutic anti-cancer agent in breast cancer therapy.


Reagents and chemicals

DMEM/F-12 media, fetal bovine serum, penicillin and streptomycin solution, rutin as well as quercetin flavonoids were procured from Sigma Aldrich, USA. Hoechst 33342 dye and MTT were purchased from Himedia, India. All the reagents utilized were of analytical grade.

PDSE preparation

Fresh Ajwa dates were obtained from a farmer of Al- Madina Al- Munawwarah city in the Kingdom of Saudi Arabia with the permission of the landowner (farmer). Mr. Muhammad Arif, Asst. Prof., Pharmacognosy Department, Integral University, Lucknow (specimen no. IU/PHAR/HRB/14/21) identified the plant material. The use of seed material in this study complied with international, national and institutional guidelines. The ethanolic extract of plant material was prepared as reported earlier with minor modifications [23]. Date fruit seeds were manually separated, washed with double distilled water, oven-dried, and coarsely powdered with a pestle and mortar. The coarse powder content was then extracted in 95% ethanol (1:3 w/v ratios) at 25 °C for three days. The extracted solvents were collected and filtered using Whatman No. 1 filter paper (125 mm). Rotavapor (BuchiRotavapor R-205, Switzerland) was used to concentrate the filtrate in a vacuum at 45 °C. The extract was concentrated further in a water bath until it formed a semi-solid paste. The extract was then stored at room temperature in an airtight container for two weeks. After getting the powdered form of PDSE, it was stored in the refrigerator at 4 oC until it was used in tests.

HPLC analysis of PDSE

An Waters 515 HPLC Pump system (Milford, USA) equipped with a W2998 PDA detector, a pump control module, a Waters column temperature controller, and an empower chromatography workstation was utilized to characterize PDSE, as reported previously [23]. An X BRIDGE C18 5 m, 4.6 × 250 mm reverse-phase column with gradient elution as the mobile phase was used for chromatographic analysis. The mobile phase was a gradient of water (Solvent A) and acetonitrile (Solvent B). Rutin and quercetin were used as standards. HPLC was examined at 257 nm to obtain real-time chromatograms of both standards and PDSE.

Cell line and culture

Human triple-negative MDA-MB-231 breast cancer, human ER and PR positive MCF-7 breast cancer, human liver HepG2 carcinoma , and normal kidney epithelial Vero cell lines were purchased from the NCCS, Pune, India. Cells were cultured in DMEM:F12 (1:1) medium in 25 cc tissue culture flasks in an incubator (Thermo Scientific, USA) as reported previously [24].

MTT assay

The anti-proliferative activity of PDSE was done by MTT assay using an established protocol [25]. Briefly, all three cancer cell lines viz. MDA-MB-231, MCF-7, HepG2 and one normal kidney epithelial cell line Vero were seeded at a density of 1 × 104 cells/mL in 96-well microtiter culture plates overnight. PDSE was dissolved in culture media for stock preparation and diluted in the same media at various concentrations ranging from 10, 25, 50, 75, and 100 μg/mL for treatment of cultured cells over a 24- and 48-h period. At the end of the incubation period, absorbance values were read using MTT dye (5 mg/mL stock) through an ELISA plate reader (Biorad-PW41, USA) at 550 nm. IC50 values were calculated using GraphPad Prism software.

Nuclear condensation assay

The apoptosis-inducing effect of PDSE was assessed at two effective doses of 50 and 100 μg/mL. Hoechst 33258 staining was used to assess nuclear condensation, as described previously [23]. In brief, cells fixation was performed using 4% paraformaldehyde following exposure with 50 and 100 µg/mL of PDSE for 48 h. After permeabilization and then staining with Hoechst 33258 (5 μg/mL) dye, cells were photographed under an inverted fluorescence microscope (Zeiss AxioVert 135, US).

Measurement of intracellular ROS

Flow cytometry technique was used to assess the intracellular ROS levels using DCFH-DA dye as described previously [23]. After 12 h exposure of PDSE,  cell were washed with PBS and incubated in PBS containing 10 μM DCFH-DA dye at 37 °C for 20 min. The cells were then washed twice with PBS and subjected to flow cytometry analysis (FACS Canto II flow cytometer, BD Biosciences, USA).

Evaluation of mitochondrial membrane potential (MMP, ΔΨm)

The fluorescent probe JC-1 was used to assess MMP changes as reported previously [23]. Briefly, cells were treated with 50 and 100 μg/mL of PDSE for 48 h. For flow cytometry analysis, cells were incubated with JC-1 dye at a final concentration of 2 μM for 30 min in the dark. After washing with PBS twice, cells were resuspended in 500 μL PBS and analyzed using flow cytometry.

Determination of apoptosis by Annexin V-FITC & PI double stain

Flow cytometry was used to quantify apoptotic cells using an Annexin V-FITC Apoptosis Kit (BioVision, USA) manufacturer’s protocol. In brief, cells at a density of 1 × 106 cells/mL were incubated for 48 h with PDSE at concentrations of 50 and 100 μg/mL. Cells were then harvested, resuspended in binding buffer and stained for 15 min at 25 °C in the dark with 2 μL Annexin V-FITC and 2 μL PI. Flow cytometry was used to assess the apoptotic index.

Analysis of cellular DNA content

Cells at density 1 × 106 cells/mL were used to  treat with 50 and 100 μg/mL concentrations of PDSE into a 6-well plate for 48 h. Flow cytometry was used to examine different stages of the cell cycle and the contents of cellular DNA, as described previously [26].

Western blot analysis

The western blotting of PDSE treated and untreated cells was carried out as per a previously published method [27]. Briefly, cell lysates were prepared in ice-cold RIPA lysis buffer containing protease and phosphatase inhibitor cocktail (Thermo Scientific). Protein sample (30 μg each) was resolved on a 10-15% SDS-PAGE gel, transferred to the nitrocellulose membrane (Millipore). Finally, the immunodetection was done using enhanced chemiluminescence (Millipore) as per manufacturer’s instructions. The full-length blots were cut before antibody hybridization and each section was incubated with primary antibody individually. Image J software (version 1.43, NIH, USA) was used to quantify the relative abundance of each band against housekeeping β-actin protein.

Molecular docking analysis through AutoDock Vina and iGEMDOCK v2.1

The binding interaction(s) of PDSE active components viz. rutin and quercetin with the apoptosis executioner protein caspase-3 was performed using AutoDock 4.2 and iGEMDOCK v2.1 [24]. PubChem database was used to access the 3D structures of rutin and quercetin components with PubChem CID: 5280805 and 5280343, respectively. Energy minimization of phytocomponents was done by ChemBio3D Ultra 14.0, with Force Field type MM2. The 3D X-ray diffraction crystal structures of caspase-3 protein (PDB ID: 2XYP; Hetero 4-mer - A2B2) were downloaded from RCSB Protein Data Bank. Complete PDB structure with no mutation and resolution 1.86 Å was selected for molecular docking study. Before docking, the refinement procedure was carried out by the addition of missing atoms to the residues, addition of polar hydrogen atoms and Kollman charges, removal of crystallographic water molecules, and external and irrelevant ligands and ions from the protein. AutoDock Vina reduces the computational effort required for binding pocket predictions. This tool was used to run docking simulations and to generate ten ligand-receptor complex conformations that were then ranked based on binding energy. iGEMDOCK can be used for post-screening analysis and predicting pharmacological interactions from screening compounds. In case of iGEMDOCK v2.1, genetic algorithm parameters were as follows: population size = 200, generations = 0 and number of solutions = 2. The best fitted was then selected displaying total binding energy in the form of van der Waals forces (VDW), hydrogen bond (HB) and electrostatic interactions (EI). AccelrysBiovia Discovery Studio 2017 R2 (Biovia, San Diego, CA, USA) was used to visualize the best docking sites and poses from both docking simulations [24, 28].

Statistical analysis 

Cell viability data were expressed as the mean ± SEM of at least three independent experiments. GraphPad Prism software was used for statistical analysis, which comprised one-way ANOVA and Dunnett’s Multiple Comparison Test (Version 5.01). A p-value of less than 0.05 was determined statistically significant.


HPLC characterization of PDSE

Figure 1a and b show photographs of Ajwa date plant and fresh Ajwa seed, respectively, whereas Fig. 1c and d show the chemical structure of the active components rutin and quercetin, respectively. Figure 1e represents the chromatogram of PDSE while Fig. 1f represents the chromatogram of reference standards rutin and quercetin along with PDSE. The peak area and percentages of different components with a specific retention time (Rt) in HPLC chromatograms are shown in Table S1. The HPLC chromatographic analysis provided a fine separation of rutin and quercetin with Rt value of 13.632 and 19.049 min, respectively at 257 nm in chromatograms (Fig. 1f). The corresponding peak of rutin and quercetin in PDSE was found with Rt of 13.401 and 19.573 min, respectively under similar conditions (Fig. 1e). This study revealed the presence of rutin and quercetin as active components in PDSE.

Fig. 1
figure 1

HPLC profile of standards rutin and quercetin and PDSE. a and b Photographs of Ajwa date plant and fresh Ajwa seeds, respectively c and d Chemical structures of rutin and quercetin e HPLC chromatogram of PDSE f HPLC chromatogram of rutin (Rt = 13.401 min) and quercetin (Rt = 19.573 min) along with PDSE

Effect of PDSE on cellular morphology and cell viability

After 24 and 48 h treatment with PDSE, MDA-MB-231, MCF-7, HepG2 and Vero cell lines were photographed . PDSE-mediated morphological variations were observed in treated and untreated cells. As shown in Figs. 2a and b; 3a and b; 4a and b, the untreated cancer cells displayed normal characteristics  viz.  typical adherent, uniform and even cell surface at both incubation periods. After a 24 h exposure, the majority of cancer cells formed a non-adherent, detached and rounded shape.  Whereas, after 48 h incubation period, PDSE increased the drastic morphological changes like typical apoptotic features in cancer cells. Thus, PDSE showed both dose- and time-dependent morphological effects. The MTT data of the MDA-MB-231 cell line revealed that PDSE reduced cell viability to 91.9, 87.8, 74.3, 61.7 and 48.4% at 10, 25, 50, 75 and 100 μg/mL PDSE, respectively, at 24 h. Conversely, PDSE exerted a more pronounced effect at 48 h, drastically reducing the viability of MDA-MB-231 treated cells to 90.5, 84, 67.6, 54.9 and 43.6% at 10, 25, 50, 75 and 100 μg/mL of PDSE, respectively (Fig. 2c). Figure 2d and e show the dose-response effect of standards rutin and quercetin, respectively at various concentrations on percent cell viability of MDA-MB-231 cells for 24 h and 48 h. The IC50 value of PDSE was found to be 101.6 and 85.86 μg/mL at 24 and 48 h, respectively. In the case of standard rutin, it was found to be 555.24 and 243.75 μM at 24 and 48 h, respectively while quercetin displayed IC50 values 285.52 and 169.05 μM at 24 and 48 h, respectively.

Fig. 2
figure 2

Evaluation of the cytotoxic activity of PDSE against human MDA-MB-231 cells at different concentrations (10–100 μg/mL) using phase contrast microscope. a and b Photomicrographs of MDA-MB-231 cells treated with 10-100 μg/mL doses  of PDSE at 24 and 48 h, respectively. Scale bar = 100 μm. c Dose-response effect of PDSE at various concentrations on percent cell viability of MDA-MB-231 cells at 24 h and 48 h using MTT assay. d and e Dose-response effect of standard compounds rutin and quercetin, respectively at various concentrations on percent cell viability of MDA-MB-231 cells at 24 h and 48 h. f Apoptosis-inducing activity of PDSE showing chromatin condensation in MDA-MB-231 treated cells at 50 and 100 μg/mL of PDSE at 48 h using Hoechst 33258 staining. Data are presented  as mean ± SEM of three independent experiments. .*p < 0.05 as compared to control

Fig. 3
figure 3

Evaluation of the cytotoxic activity of PDSE against human MCF-7 cells at different concentrations (10–100 μg/ml) using phase contrast microscope. a and b Photomicrographs of MCF-7 cells treated with 10–100 μg/mL concentrations of PDSE at 24 and 48 h, respectively. Scale bar = 100 μm. c Dose-response effect of PDSE at various concentrations on percent cell viability of MCF-7 cells at 24 h and 48 h using MTT assay. d Apoptosis-inducing activity of PDSE showing chromatin condensation in MCF-7 treated cells at 50 and 100 μg/mL of PDSE at 48 h using Hoechst 33258 staining. Values are presented  as mean ± SEM of three independent experiments. *p < 0.05 as compared to control

Fig. 4
figure 4

Evaluation of the cytotoxicactivity of PDSE against human HepG2 cells at different concentrations (10–100 μg/ml) using phase contrast microscope. a and b Photomicrographs of HepG2 cells treated with 10–100 μg/mL concentrations of PDSE at 24 and 48 h, respectively. Scale bar = 100 μm. c Dose-response effect of PDSE at various concentrations on percent cell viability of HepG2 cells at 24 h and 48 h using MTT assay. d Apoptosis-inducing activity of PDSE showing chromatin condensation in HepG2 treated cells at 50 and 100 μg/mL of PDSE at 48 h using Hoechst 33258 staining. Data are presented as mean ± SEM of three independent experiments. *p < 0.05 as compared to control

Likewise, PDSE at 10, 25, 50, 75 and 100 μg/mL decreased the cell viability to 96.4, 90.9, 82.3, 69.6 and 51% post 24 h incubation; and to 92.8, 86.5, 77, 61.3 and 46.4% at 48 h incubation, respectively in MCF-7 cell line (Fig. 3c). Similarly, PDSE at concentrations 10, 25, 50, 75 and 100 μg/mL decreased the cell viability to 96.1, 92.3, 84.3, 75.1 and 62.6% at 24 h incubation; and 94.5, 90.8, 81.1, 71.1 and 55.1% at 48 h incubation, respectively in HepG2 cell line (Fig. 4c). The cell viability data suggested that PDSE treatment significantly reduced cancer cell growth in both doses- and time-dependent manner. However, PDSE did not exert any significant morphology variation and effect on survival of normal cell line Vero as represented in Fig. 5a and b at both 24 and 48 h, respectively. The percent cell viability of Vero cells at concentrations 10, 25, 50, 75 and 100 μg/mL was found to be 98.0, 98.2, 95.5, 94.2 and 93.8% at 24 h incubation and 96.7, 95.6, 93.6, 91.9 and 87.2% at 48 h incubation period, respectively (Fig. 5c).

Fig. 5
figure 5

Evaluation of the cytotoxicactivity of PDSE against normal kidney epithelial cell line Vero at different concentrations (10–100 μg/ml) using phase contrast microscope. a and b Photomicrographs of Vero cells treated with 10–100 μg/mL concentrations of PDSE at 24 and 48 h, respectively. Scale bar = 100 μm. c Dose-response effect of PDSE at various concentrations on percent cell viability of Vero cells at 24 h and 48 h using MTT assay. Data are presented as mean ± SEM of three independent experiments

Apoptotic body formation by PDSE

Based on cell viability data, two effective doses 50 and 100 μg/mL were selected to study the chromatin condensation in different cancer cell lines at 48 h incubation period. As apparent from the photomicrograph (Fig. 2f), PDSE at 50 μg/mL concentration increased the chromatin condensation in MDA-MB-231 cells as compared to control, however, 100 μg/mL of PDSE exhibited comparatively greater nuclear condensation under the inverted fluorescence microscope. Similar effects of nuclear condensation were observed against both MCF-7 and HepG2 cell lines as shown in Figs. 3d and 4d, respectively. Figures 2f, 3d and Fig. 4d show that PDSE induced pronounced nuclear apoptosis in MDA-MB-231 cell lines when compared to other cancer cells.

PDSE causes intracellular ROS production 

ROS measurement through flow cytometry analysis revealed that the mean fluorescence intensity of DCFDA dye in MDA-MB-231 control cells was 185.47 which was decreased to 95.71 and 68.11 at 50 and 100 μg/mL of PDSE treatment, respectively indicating a decrease in intracellular ROS levels (Fig. 6a and b).

Fig. 6
figure 6

Intracellular ROS generation and apoptosis-inducing activityof PDSE in human MDA-MB-231 cells using DCFH-DA and annexin V/FITC & PI double stains, respectively. a DCFDA fluorescence in the cells is represented as the percentage of ROS production analyzed using flow cytometry b Graph showing mean fluorescence intensity. c Representative scatter plot from flow cytometry showing the population of viable (annexin V PI), early apoptotic (annexin V+ PI), late apoptotic (annexin V+ PI+) and necrotic (annexin V PI+) cells. d Graph showing total percentage of apoptotic cells analyzed by flow cytometry. *p < 0.05 and **p < 0.01 when compared to the control group

Apoptosis quantification at early and late stage 

Apoptosis Detection Kit (Annexin V-FITC) was used further to examine the early and late apoptotic cells. Untreated cells demonstrated negligible apoptosis and dead cells, while PDSE at 50 μg/mL promoted cell death by lowering the number of viable cells and enhancing the percentage of early (19.8%) and late (18.97%) apoptotic cells. The concentration 100 μg/mL promoted the proportion of early and late apoptotic cells to 21.5 and 19.61%, respectively (Fig. 6c and d). This indicates that a high dose of PDSE induced early and late apoptosis in treated cells.

Decrease in MMP by PDSE

As evident from flow cytometry data (Fig. 7), PDSE treatment resulted in an increase in green fluorescence by 62.61% at 50 μg/mL and 78.15% at 100 μg/mL doses as compared to untreated control. Further, a decrease in the ratio of aggregate (red fluorescence) to monomer (green fluorescence) was observed after PDSE treatment in MDA-MB-231 cells indicating a loss in mitochondrial membrane potential.

Fig. 7
figure 7

Concentration dependent effects of PDSE on the MMP changes in human MDA-MB-231 cells analyzed using JC-1 dye by flow cytometry. a JC-1 fluorescent dyes can aggregate in the matrix of mitochondria and produce red fluorescence. As MMP declines, JC-1 cannot aggregate so JC-1 exists in the matrix as a monomer, producing green fluorescence b Graph showing ratio of aggregate/monomer fluorescence in the cells. As the concentration of PDSE increased, the ratio declined. *p < 0.05, **p < 0.01 and ***p < 0.001 as compared to control group

Induction of S phase arrest by PDSE

Treated and untreated MDA-MB-231 cells were analyzed for cell cycle check points through flow cytometer. Figure 8a depicts the cytogram showing the proportion of MDA-MB-231 cells in different phases of the cell cycle and Fig. 8b represents the quantification of flow cytometry data. As revealed by cell cycle data (Fig. 8a), PDSE increased the DNA content (28.25% in untreated control versus 48.02% at 50 μg/mL and 50.50% at 100 μg/mL of PDSE) in the S phase of MDA-MB-231 cells with a concomitant decrease in the percentage of cells in the G0/G1 phase (50.11% in untreated control versus 37.10% at 50 μg/mL and 25.35% at 100 μg/mL of PDSE). PDSE also increased the percentage of SubG1 cells viz. 27.62 and 37.07% at 50 and 100 μg/mL as compared to untreated control. These results indicate that PDSE arrested the MDA-MB-231 cells in the S phase of the cell cycle.

Fig. 8
figure 8

Flow cytometry results depicting effect of PDSE on cell cycle. a Histogram from flow cytometry showing the percentage of MDA-MB-231cells in different phases of cell cycle treated with 50 and 100 μg/mL of PDSE for 48 h b Quantification of flow cytometry data shown in right lower panel

Effects of PDSE on anti-apoptotic and pro-apoptotic proteins

To analyze the underlying mechanisms of PDSE-induced cell death, western blotting was performed for the expression analysis of key apoptotic proteins viz. pro-apoptotic Bax, tumor suppressor p53, anti-apoptotic Bcl-2, effector caspase-3 and cleaved PARP-1. Results showed that pro-apoptotic protein Bax was upregulated, but it was independent of tumor suppressor protein p53 while anti-apoptotic protein Bcl-2 was down-regulated in 100 μg/mL PDSE treated cells. The cleaved caspase-3 protein expression was augmented in the MDA-MB-231 cancer cells, after 48 h of PDSE treatment. The expression of p53 did not increase significantly which means that PDSE induced cell death via a p53 independent pathway. PARP1, an enzyme involved in the repair of damaged DNA, is a preferential substrate for caspase-3. PDSE caused the cleavage of PARP1 in a dose-dependent manner in MDA-MB-231 cells (Fig. 9). These results indicate that PDSE induces apoptosis through intrinsic apoptotic pathways in breast cancer cells.

Fig. 9
figure 9

Immunoblot analysis showing the expression levels of p53, Bax, Bcl2, cleaved Caspase-3 and PARP-1 cleavage. MDA-MB-231 cells were treated at two effective concentrations of PDSE (50 and 100 μg/mL) for 48 h. Equal amounts of protein samples (30 μg/lane) were resolved on SDS-PAGE gel and transferred to nitrocellulose membrane. Expression of p53, Bax, Bcl2, cleaved Caspase-3, PARP-1 cleavage and β-actin were detected using specific antibodies. Lane 1: 0 μg/mL (Untreated); Lane 2: 50 μg/mL; Lane 3: 100 μg/mL of PDSE. Protein markers p53, Bcl2, cleaved Caspase-3, and one of the β-actin proteins were cropped from different parts of the same blot, while Bax, PARP-1 cleavage, and other β-actin proteins were cropped from different blots. β-actin was used as a loading control. The full-length blots were cut prior to antibody hybridization and each section was incubated with primary antibody individually. A high background signal was seen in the p53 blot, masking the expression of p53, thus this blot was excised at the time of developing the film. Full-length blots are shown in Supplementary Fig. S1. The data represents the mean ± SEM of three independent experiments. *p < 0.05 compared to the control group

Binding analysis of rutin and quercetin present in  PDSE against caspase-3 protein

The docking tools AutoDock Vina and iGEMDOCK v2.1 were used to study the binding interaction of rutin and quercetin present in PDSE with a caspase-3 target protein. The docking results obtained from both docking tools were visualized by BIOVIA Discovery Studio software. AutoDock Vina is based on the statistical scoring function that replaces the semi-empirical free energy force field of AutoDock 4.2. AutoDock Vina provides improved prediction accuracy and speed, which is not only due to the simplification of the scoring function but also due to the capability of multi-threading in presence of multiple CPU cores. Figure 10a and b depict the molecular structure of rutin and quercetin, respectively; Fig. 10c represents the 3-D crystal structure of a caspase-3 protein; Figs. 10d and Fig. 10e depict the docking interaction of rutin and quercetin complexed with caspase-3 protein, respectively as analyzed by AutoDock Vina while Fig. 10f and g are destined for rutin and quercetin, respectively as analyzed by iGEMDOCK v2.1 tool. Table 1 represents the active constituents of PDSE with their chemical structure, binding energy, dissociation constant, best docking poses with amino acid residues contributing to the binding pocket of the caspase-3 protein. As shown in Table 1, rutin and quercetin phytoconstituents exhibited potent binding interaction with caspase-3 protein. As analyzed by AutoDock Vina, the binding energy of rutin (BE = − 9.1 kcal/mol) was found to be lower than the binding energy of quercetin (BE = − 7.6 kcal/mol), which means that the binding affinity of rutin with caspase-3 protein is greater than quercetin. These results were further confirmed from analysis using iGEMDOCK v2.1, which showed consistent results with both components. The result suggests that both ligands have different binding sites and hence possess different binding energies towards caspase-3 protein.

Fig. 10
figure 10

Visualization of binding poses of rutin and quercetin in the binding site of caspase-3 protein (PDB ID: 2XYP; Hetero 4-mer - A2B2) using Accelrys Biovia Discovery Studio 2017 R2. a Molecular structure of rutin b Molecular structure of quercetin c 3-D crystal structure of Caspase-3 protein d & e Docking interaction of rutin-caspase-3 complex and quercetin-caspase-3 complex analyzed by AutoDock Vina, respectively. f & g Docking interaction of rutin-caspase-3 complex and quercetin-caspase-3 complex analyzed by iGEMDOCK v2.1, respectively. In AutoDock Vina, the ligand-protein complex is represented by the 2-D line model, whereas in iGEMDOCK v2.1 analyses, the ligand is represented by the stick model. The dark green dotted line represents H - bond

Table 1 Docking interactions of rutin and quercetin active components present in PDSE with executioner caspase-3 protein (PDB ID: 2XYP; Hetero 4-mer - A2B2) using AutoDock Vina and iGEMDOCK v2.1


Cancer is a foremost health problem that affects millions of people across the world. At present, chemotherapy is considered one of the most effective cancer treatment strategies. Although chemotherapy significantly improves the prognosis of cancer patients, but this approach is not free from side effects. Chemotherapeutic drugs can damage normal, healthy cells resulting in side effects like hair loss, anemia, sores, nerve, muscle as well as kidney and fertility problems [29]. To avoid side effects, most cancer patients adopt alternative therapy based on herbal medicines. Plant-based cancer treatment is considered a better treatment option because phytotherapeutic agents are natural, readily available, easily assimilated in the body, and have fewer side effects and toxicity.

Medicinal plants are well known for their antioxidant and immunomodulatory properties, as well as their anticancer activities [9, 30]. The seeds of Ajwa dates are abundant in minerals, vitamins, dietary fibers, phenolic compounds, and different flavonoids [17]. Evidence indicates that individuals with a high intake of dietary fiber and phenolic compounds have reduced incidence of colorectal, prostate, lung, breast and ovarian cancer(s) [31,32,33]. Previous studies have shown that date palm seeds induce immunity in broiler chickens [34], cause an increase in the paraoxonase and arylesterase activities in hypercholesterolemic rats [35] and enhance the endogenous insulin secretion in type 1 diabetic rats [36]. An earlier study has also found that a combination of black pepper and Ajwa seed extract normalizes glucose levels and liver enzymes aspartate transaminase, alanine transaminase and alkaline phosphatase activities in alloxan-induced diabetic rats [37]. The therapeutic potential of PDSE has been investigated against DNA damage induced by N-nitroso-N-methyl urea (NMU) in mice [38] and carbon tetrachloride (CCl4)-induced hepatotoxicity in rats [15]. The protective role of PDSE against gastric ulcers has also been investigated [39]. Two ex vivo studies have been carried out to evaluate the efficacy of date seed oil extract to prevent oxidative stress; a major contributor towards cancer development [40, 41]. Moreover, a study has shown that acetone extract of date palm seeds is highly cytotoxic against human colorectal cancer cell line HCT-15 and has significant antibacterial activity against Bacillus cereus and Escherichia coli [42]. However, further experimental work needs to be performed to confirm the previous traditional applications of Ajwa date seeds in cancer treatment. The current study not only presents a novel approach to understand the anticancer activity but also augments the existing knowledge about the traditional use of the PDSE. Although previous studies have reported the antidiabetic, hypolipidemic and antioxidant properties of PDSE [43, 44], the cytotoxic effects of PDSE against human breast cancer cell lines MDA-MB-231 and MCF-7 and human liver cancer cell line HepG2 remain to be investigated. This study also attempted the HPLC characterization of PDSE to find the major active component(s) that might be contributing to the anticancer potential of the extract. Moreover, in silico molecular docking analysis between active components, viz. rutin and quercetin with apoptosis executioner caspase-3 protein further validated the anticancer potential of PDSE. For a comprehensive summary, Fig. 11 summarizes the phytochemical analysis, several in vitro anticancer parameters, and in silico analysis.

Fig. 11
figure 11

A comprehensive summary of the current study representing the phytochemical analysis of PDSE, in vitro anticancer study against liver and breast cancer cells and in silico analysis of PDSE active components with caspase-3 targeted protein

The cell viability data indicated that PDSE had a cytotoxic effect against MDA-MB-231 cells with IC50 values of 101.6 and 85.86 μg/mL following 24 and 48 h incubation, respectively. Likewise, PDSE induced cell death in MCF-7 cell line having IC50 values of 107.8 and 99.9 μg/mL following 24 and 48 h incubation, respectively; and IC50values of 147.3 and 122.3 μg/mL against HepG2 cell line following 24 and 48 h incubation, respectively. PDSE toxicity was shown to be higher in MDA-MB-231 cells (IC50 = 85.86 μg/mL) than in the other two cancer cell lines (MCF-7 and HepG2 cells). PDSE showed modest cytotoxicity on each kind of cancer cell after 48 h, resulting in minor changes in IC50 value. Cytotoxic potential of PDSE was reduced in the following order: MDA-MB-231 > MCF-7 > HepG2. MDA-MB-231 cells exhibit an estrogen-independent state and do not express estrogen receptors and hence they are ideal models for chemotherapeutic studies, however, MCF-7 cells possess estrogen and progesterone receptors and hence they are suitable models for investigations on hormone therapy [45]. Based on this principle, it can be concluded that PDSE could be a better therapeutic agent for the growth inhibition of triple-negative breast cancer cell line MDA-MB-231. A previous study has reported that hydromethanolic extract of Ardisia crispa showed moderate cytotoxic effect against MCF-7 and a weak cytotoxic effect against MDA-MB-231 [46]. Conversely, another study has stated that hexane fraction of Acanthopanax sessiliflorus stem bark extract displayed more cytotoxicity against MDA-MB-231 cells compared to MCF-7 cells [47]. Interestingly, in agreement with this previous study, ethanolic PDSE was found to be more cytotoxic against MDA-MB-231 cells as compared to MCF-7 cells. In addition, PDSE did not exert any significant morphology variation and toxic effect on survival of normal cell line Vero as represented (Fig. 5). Furthermore, the present study involved an investigation into the mechanism(s) responsible for PDSE mediated cytotoxicity. There are two major pathways of cell death viz. apoptosis or necrosis. Results of nuclear condensation by Hoechst staining revealed that PDSE-treated cancer cells exhibited the hallmark features of apoptosis viz. cell shrinkage, nuclear chromatin condensation and formation of fragmented apoptotic bodies [23] (Figs. 2f, 3d, and 4d). Previous studies have also reported the apoptotic effect of several plant extracts against different cancer cell lines [48,49,50].

In cancer cells, high levels of ROS have been detected due to increased metabolic and peroxisomal activities, mitochondrial dysfunction, increased receptor signaling, oncogenic activity, increased enzymatic activity of oxidases, lipoxygenases, cyclooxygenases and thymidine phosphorylase [51]. In this study, PDSE decreased the level of ROS in treated MDA-MB-231 cells, which indicates that PDSE induced cell death independent of ROS pathway. ROS-independent cell apoptosis pathway has rarely been reported in cancer cells and may act as a natural regulator of important signaling pathways in cells [52]. Therefore, it can be expected that ROS signaling does not influence the mechanisms of PDSE-induced cell death. Interestingly, in earlier research, several prospective compounds viz. metformin, quercetin, curcumin and vitamin C have been found to downregulate ROS in the cellular apoptotic process and some of them have even been demonstrated to promote apoptosis in cancer cells [53]. Further, based on initial study of nuclear condensation, MDA-MB-231 cells were stained with Annexin-V-FITC/PI double stain and examined by flow cytometry. Results showed that the percentage of live cells was decreased with a simultaneous increase in early and late apoptosis of the cells. This study suggests that high dose of PDSE increases the percentage of cells undergoing late apoptosis (Fig. 6c). Similarly, in a previous study, methanolic extract of Ajwa dates pulp has been reported to increase the percentage of MCF-7 cells undergoing late apoptosis [54].

Mitochondria is not only the ATP factory of energy but also help in the regulation of the membrane potential, apoptosis, calcium signaling and regulation of cellular metabolism [55]. The efficacy of cancer therapy can be improved by altering the cellular metabolism of tumor cells or promoting MMP decrease. Permeabilization of the inner mitochondrial membrane causes disruption of MMP and thus, a decline of MMP is associated with the opening of a mitochondrial permeability transition pore which results in the rupture of the outer mitochondrial membrane and release of various apoptosis factors such as Cyt c, Smac, Endo G into the cytoplasm, finally leading to cell apoptosis [56]. The present study revealed that PDSE declined the MMP level by changing the JC-1 fluorescent color from red to green, suggesting that depletion of MMP is associated with the increasing concentration of PDSE. Cell cycle analysis showed that PDSE treatment resulted in S phase arrest of cell cycle followed by apoptosis in MDA-MB-231 cancer cells (Fig. 5). This study confirmed that PDSE hampers the initiation of DNA replication and thus arrests MDA-MB-231 cells at the S phase. Apoptotic events also require permeabilization of the outer membrane of the mitochondria which is regulated by the Bcl-2 family proteins. Based on the role of Bcl-2 family proteins, this study was also formulated to analyze protein expression of p53, Bax, Bcl-2, cleaved caspase-3 and PARP-1 cleavage in PDSE- treated cancer cells. Western blot analysis revealed that PDSE increased the expression level of pro-apoptotic Bax and effector cleaved caspase-3, whereas PDSE downregulated the anti-apoptotic Bcl-2 protein level (Fig. 9). While, PDSE did not reduce the tumor suppressor p53 protein, indicating PDSE induced cell death via p53 independent pathway. Following activation, Bax and Bak form homo-oligomers deactivating Bcl-2 protein and contribute to pore formation which causes permeabilization of the outer mitochondrial membrane, leading to the release of mitochondrial inner membrane space contents, including Cyt c and Smac, into the cytosol [57]. These contents drive the activation of apoptotic effector caspases including caspase-3 that cleave and degrade the crucial PARP protein, a DNA repair enzyme leading to DNA breakage and cellular apoptosis [58]. The apoptosis executioner enzyme caspase-3 is the main proteolytic cascade involved in the apoptosis of both intrinsic and death receptor pathways [59]. Western blot data indicated that PDSE induced cellular apoptosis through intrinsic pathways in breast cancer cells.

PDSE was further characterized using HPLC to identify the phytoconstituents present therein. Rutin and quercetin were the principal phytochemicals identified in PDSE. Rutin and quercetin are the most widely distributed plant flavonoids and major constituents of the human diet [60, 61]. Previous studies have confirmed the anticancer activities of both bioactive agents against different human cancer cell lines [62,63,64]. In our recent publications, the pulp extract of Ajwa dates has shown IC50 values of 20.03 and 16.78 mg/mL at 24 and 48 h periods, respectively, against human liver cancer HepG2 cells and IC50 values of 17.45 and 16.67 mg/mL at 24 and 48 h, respectively against TNBC MDA-MB-231 cells [23, 65]. While the active components of Ajwa date pulp extract in the previous study was β-D-glucan (a polysaccharide), rutin and quercetin were the active phytoconstituents identified in PDSE. Lower doses of PDSE were required as compared to Ajwa dates pulp extract, which suggests that seed extract has comparatively more potential against cancer cells as compared to pulp extract of Ajwa dates. Furthermore, an in silico computational study was carried out using chemoinformatic tools to validate caspase-3 activation. As caspase-3 is the main executioner protein accountable for apoptosis and also shares many structural characteristics with other-known caspases [59], thus, caspase-3 was selected as a potential target protein for ligand-protein binding affinity. Moreover, caspase-3 is active over a broad pH range [66], which indicates that caspase-3 would be fully active under normal and apoptotic cell conditions.

Caspase-3, (also called apopain) is synthesized in the cell in its zymogen form of 32 kDa, consisting of an N-terminal pro-domain followed by a large 17 kDa (p17) and small 12 kDa (p12) subunit linked to each other by an inter-subunit linker. Caspase-3 in its functional form is a heterotetramer; formed by hydrophobic interactions of four anti-parallel beta-sheets from p17 and two from p12 subunits. Beta-sheet interacts with another heterodimer resulting in a 12-stranded beta-sheet structure, around which alpha- helices are positioned. A previous study has shown that catalytic residues of caspase-3 consist of sulfhydryl group of Cys-163 and the imidazole ring of His-121 [67]. The large subunit p17 harbors the active site catalytic dyad residues and the small subunits contain most of the dimer interface and the allosteric site [68]. Interestingly, as revealed by in silico binding interaction data using AutoDock Vina and iGEMDOCK v2.1 tools, rutin present in PDSE did not interacted with any catalytic residue, while quercetin interacted with both catalytic residues His121 and Cys163 in addition to other amino acid residues in the binding pocket of caspase-3 (Table 1). As is apparent from binding interactions of amino acid residues in both AutoDock Vina and iGEMDOCK v2.1 analyses, the slight variations in interacting amino acid residues are because of the differences in the grid box generation and determination of binding pockets on the target protein [28].


The current study revealed the cytotoxic activity of PDSE against breast and liver cancer and apoptotic potential against TNBC MDA-MB-231 cells. This activity could be attributed to the synergistic effect of bioactive agents particularly rutin and quercetin present in PDSE. Moreover, in silico analysis confirmed the potential binding affinity of rutin and quercetin with amino acid residues of caspase-3 executioner protein. However, because caspase-3 is a downstream protein, the apoptotic effect of PDSE in upstream pathways cannot be rationalized by binding these bioactive compounds to caspase-3. As a result, further study is warranted for upstream target-protein(s) docking studies, as well as the isolation of bioactive compounds from PDSE and their mechanisms of action in vitro and in vivo. These studies would lead to a more complete assessment of PDSE and its feasibility as a future anticancer drug candidate and an adjunct.

Availability of data and materials

The datasets used and analyzed in the current study are included in this article.


CCl4 :

Carbon tetrachloride


Dimethyl sulfoxide


Dulbecco’s Modified Eagle Medium Nutrient Mixture F-12


Fetal bovine serum


High performance liquid chromatography


mitochondrial membrane potential


3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide




Phoenix dactylifera seed extract


Phosphate- buffered saline


Reactive oxygen species


Radio immune precipitation assay


Sodium dodecyl sulphate- polyacrylamide gel electrophoresis


Triple negative breast cancer


  1. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today.  Lyon: International Agency for Research on Cancer; 2022. Accessed 21 Feb 2022.

  2. WHO-fact sheet. 2021. Accessed 25 Aug 2021.

  3. Global Cancer Statistics. 2020.

  4. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

    PubMed  Google Scholar 

  5. Malvia S, Bagadi SA, Dubey US, Saxena S. Epidemiology of breast cancer in Indian women. Asia Pac J ClinOncol. 2017;13:289–95.

    Google Scholar 

  6. Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 2020;83(3):770–803.

    Article  CAS  PubMed  Google Scholar 

  7. Christensen SB. Natural Products That Changed Society. Biomedicines. 2021;9(5):472.

  8. Nwodo JN, Ibezim A, Simoben CV, Ntie-Kang F. Exploring cancer therapeutics with natural products from African medicinal plants, part II: alkaloids, terpenoidsand flavonoids. Anti Cancer Agents Med Chem. 2016;16:108–27.

    CAS  Google Scholar 

  9. Sofowora A, Ogunbodede E, Onayade A. The role and place of medicinal plants in the strategies for disease prevention. Afr J Tradit ComplementAltern Med. 2013;10:210–29.

    Google Scholar 

  10. Teall EK. Medicine and doctoring in ancient Mesopotamia. Gd Val J Hist. 2013;3(1):2.

  11. Shanmugapriya M, Patwardhan K. 27 Uses of Date Palm in Ayurveda. Dates: production, processing, food, and medicinal values. 2012;20:377.

    Google Scholar 

  12. Böck B. “When you perform the ritual of 'rubbing”: on medicine and magic in ancient Mesopotamia. J Near East Stud. 2003;62(1):1–16.

    PubMed  Google Scholar 

  13. Rahmani AH, Aly SM, Ali H, Babiker AY, Srikar S, Khan AA. Therapeutic effects of date fruits (Phoenix dactylifera) in the prevention of diseases via modulation of anti-inflammatory, anti-oxidant and anti-tumour activity. Int J Clin Exp Med. 2014;7(3):483–91.

    PubMed  PubMed Central  Google Scholar 

  14. Duke JA. Handbook of phytochemical constituents of GRAS herbs and other economic plants: CRC Press; 1992.

    Google Scholar 

  15. Abdelaziz DH, Ali SA. The protective effect of Phoenix dactylifera L. seeds against CCl4-induced hepatotoxicity in rats. J Ethnopharmacol. 2014;155(1):736–43.

    PubMed  Google Scholar 

  16. Aljuhani N, Elkablawy MA, Elbadawy HM, Alahmadi AM, Aloufi AM, Farsi SH, et al. Protective effects of Ajwa date extract against tissue damage induced by acute diclofenac toxicity. J Taibah Univ Med Sci. 2019;14(6):553–9.

    PubMed  PubMed Central  Google Scholar 

  17. Khalid S, Khalid N, Khan RS, Ahmed H, Ahmad A. A review on chemistry and pharmacology of Ajwa date fruit and pit. Trends Food Sci Technol. 2017;63:60–9.

    CAS  Google Scholar 

  18. Martin TA, Ye L, Sanders AJ, Lane J, Jiang WG. Cancer invasion and metastasis: molecular and cellular perspective. In: Madame Curie Bioscience Database. Austin: Landes Bioscience; 2013.

  19. Jos A, Repetto G, Rios JC, Hazen MJ, Molero ML, del Peso A, et al. Ecotoxicological evaluation of carbamazepine using six different model systems with eighteen endpoints. Toxicol in Vitro. 2003;17(5–6):525–32.

    CAS  PubMed  Google Scholar 

  20. Romero D, Gómez-Zapata M, Luna A, García-Fernández AJ. Morphological characterization of renal cell lines (BGM and VERO) exposed to low doses of lead nitrate. HistolHistopathol. 2004;19(1):69–76.

    CAS  Google Scholar 

  21. Fernández Freire P, Peropadre A, Pérez Martín JM, Herrero O, Hazen MJ. An integrated cellular model to evaluate cytotoxic effects in mammalian cell lines. Toxicol Vitro. 2009;23(8):1553–8.

    Google Scholar 

  22. Kumar S, Kanwar S, Bansal V, Sehgal R. Standardization and validation of Vero cell assay for potency estimation of diphtheria antitoxin serum. Biologicals. 2009;37(5):297–305.

    CAS  PubMed  Google Scholar 

  23. Siddiqui S, Ahmad R, Khan MA, Upadhyay S, Husain I, Srivastava AN. Cytostatic and anti-tumor potential of Ajwa date pulp against human hepatocellular carcinoma HepG2 cells. Sci Rep. 2019;9:1.

    Google Scholar 

  24. Siddiqui S, Upadhyay S, Ahmad R, Gupta A, Srivastava A, Trivedi A, et al. Virtual screening of phytoconstituents from miracle herb Nigella sativa targeting nucleocapsid protein and papain-like protease of SARS-CoV-2 for COVID-19 treatment. J Biomol Struct Dyn. 2020;8:1–21.

    CAS  Google Scholar 

  25. Siddiqui S, Arshad M. Osteogenic potential of punicagranatum through matrix mineralization, cell cycle progression and runx2 gene expression in primary rat osteoblasts. Daru. 2014;22:72.

    PubMed  PubMed Central  Google Scholar 

  26. Ahamad MS, Siddiqui S, Jafri A, Ahmad S, Afzal M, Arshad M. Induction of apoptosis and antiproliferative activity of naringenin in human epidermoid carcinoma cell through ROS generation and cell cycle arrest. PLoS One. 2014;9(10):e110003.

    PubMed  PubMed Central  Google Scholar 

  27. Thakur R, Trivedi R, Rastogi N, Singh M, Mishra DP. Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer. Sci Rep. 2015;5(1):1–6.

    Google Scholar 

  28. Ahmad R. Steroidal glycoalkaloids from Solanumnigrum target cytoskeletal proteins: an in silico analysis. PeerJ. 2019;3(7):e6012.

    Google Scholar 

  29. American cancer society. 2021. Accessed July 2021.

  30. Kumar D, Arya V, Kaur R, Bhat ZA, Gupta VK, Kumar V. A review of immunomodulators in the Indian traditional health care system. J Microbiol Immunol Infect. 2012;45:165–84.

    CAS  PubMed  Google Scholar 

  31. Shankar S, Lanza E. Dietary fiber and cancer prevention. Hematol Oncol Clin North Am. 1991;5:25–41.

    CAS  PubMed  Google Scholar 

  32. Kunzmann AT, Coleman HG, Huang WY, Kitahara CM, Cantwell MM, Berndt SI. Dietary fiber intake and risk of colorectal cancer and incident and recurrent adenoma in the prostate, lung, colorectal, and ovarian Cancer screening trial. Am J Clin Nutr. 2015;102:881–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Carocho M, Ferreira CFR, I. The role of phenolic compounds in the fight against cancer–a review. Anti Cancer Agents Med Chem. 2013;13(8):1236–58.

    CAS  Google Scholar 

  34. El-Far AH, Ahmed HA, Shaheen HM. Dietary supplementation of Phoenix dactylifera seeds enhances performance, immune response, and antioxidant status in broilers. Oxidative Med Cell Longev. 2016;2016:5454963.

    Google Scholar 

  35. Takaeidi MR, Jahangiri A, Khodayar MJ, Siahpoosh A, Yaghooti H, Rezaei S, et al. The effect of date seed (Phoenix dactylifera) extract on paraoxonase and arylesterase activities in hypercholesterolemic rats. Jundishapur J Nat Pharm Prod. 2014;9:30–4.

    PubMed  PubMed Central  Google Scholar 

  36. El Fouhil AF, Ahmed AM, Atteya M, Mohamed RA, Moustafa AS, Darwish HH. An extract from date seeds stimulates endogenous insulin secretion in streptozotocin-induced type I diabetic rats. Func Foods Health Dis. 2013;3:441–6.

    Google Scholar 

  37. Sarfraz M, Khaliq T, Khan JA, Aslam B. Effect of aqueous extract of black pepper and ajwa seed on liver enzymes in alloxan-induced diabetic Wister albino rats. Saudi Pharml J. 2017;25(4):449–52.

    Google Scholar 

  38. Diab KA, Aboul-Ela E. In vivo comparative studies on antigenotoxicity of date palm (Phoenix dactylifera L.) pits extract against DNA damage induced by N-nitroso-N-methylurea in mice. Toxicol Int. 2012;19:279–86.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Al-Qarawi AA, Abdel-Rahman H, Ali BH, Mousa HM, El-Mougy SA. The ameliorative effect of dates (Phoenix dactylifera L.) on ethanol-induced gastric ulcer in rats. J Ethnopharmacol. 2005;98(3):313–7.

    CAS  PubMed  Google Scholar 

  40. Dammak I, Boudaya S, Abdallah FB, Hamida T, Attia H. Date seed oil inhibits hydrogen peroxide-induced oxidative stress in normal human epidermal melanocytes. Connect Tissue Res. 2009;50:330–5.

    PubMed  Google Scholar 

  41. Ines D, Sonia B, Fatma BA, Souhail B, Hamadi A, Hamida T, et al. Date seed oil inhibits hydrogen peroxide-induced oxidative stress in human epidermal keratinocytes. Int J Dermatol. 2010;49:262–8.

    CAS  PubMed  Google Scholar 

  42. Sundar RD, Segaran G, Shankar S, Settu S, Ravi L. Bioactivity of Phoenix dactylifera seed and its phytochemical analysis. Int J Green Pharm. 2017;11(2):S292–7.

  43. Khan TJ, Kuerban A, Razvi SS, Mehanna MG, Khan KA, Almulaiky YQ, et al. In vivo evaluation of hypolipidemic and antioxidative effect of ‘Ajwa’ (Phoenix dactylifera L.) date seed-extract in high-fat diet-inducedhyperlipidemic rat model. Biomed Pharmacother. 2018;107:675–80.

    CAS  PubMed  Google Scholar 

  44. Hasan M, Mohieldein A. In vivo evaluation of anti diabetic, hypolipidemic, antioxidative activities of Saudi date seed extract on streptozotocin induced diabetic rats. J Clin Diagn Res. 2016;10:FF06-12.

    PubMed  Google Scholar 

  45. Husain I, Ahmad R, Chandra A, Raza ST, Shukla Y, Mahdi F. Phytochemical characterization and biological activity evaluation of ethanolic extract of Cinnamomumzeylanicum. J Ethnopharmacol. 2018;219:110–6.

    CAS  PubMed  Google Scholar 

  46. Nordin ML, Kadir AA, Zakaria ZA, Abdullah R, Abdullah MN. In vitro investigation of cytotoxic and antioxidative activities of Ardisiacrispa against breast cancer cell lines, MCF-7 and MDA-MB-231. BMC Complement Altern Med. 2018;18:87.

    PubMed  PubMed Central  Google Scholar 

  47. Thamizhiniyan V, Young-Woong C, Young-Kyoon K. The cytotoxic nature of Acanthopanaxsessiliflorus stem bark extracts in human breast cancer cells. Saudi J Biol Sci. 2015;22:752–9.

    PubMed  PubMed Central  Google Scholar 

  48. Ahmad R, Fatima A, Srivastava AN, Khan MA. Evaluation of apoptotic activity of Withaniacoagulansmethanolic extract against human breast cancer and Vero cell lines. J Ayurveda Integr Med. 2017;8:177–83.

    PubMed  PubMed Central  Google Scholar 

  49. Ahmad R, Gupta A, Fatima A, Husain I, Srivastava AN. The evaluation of biological activity of methanolic extracts of Solanumnigrum and molecular docking analysis of selected phytoconstituents against vimentin. J Intercult Ethnopharmacol. 2017;6:391–400.

    CAS  Google Scholar 

  50. Atmaca H, Bozkurt E, Cittan M, Tepe HD. Effects of Galiumaparine extract on the cell viability, cell cycle and cell death in breast cancer cell lines. J Ethnopharmacol. 2016;186:305–10.

    CAS  PubMed  Google Scholar 

  51. Liou GY, Storz P. Reactive oxygen species in cancer. Free Radic Res. 2010;44(5):479–96.

    CAS  PubMed  Google Scholar 

  52. Perillo B, Di Donato M, Pezone A, Di Zazzo E, Giovannelli P, Galasso G, et al. ROS in cancer therapy: the bright side of the moon. ExpMol Med. 2020;52(2):192–203.

    CAS  Google Scholar 

  53. Jeong CH, Joo SH. Downregulation of reactive oxygen species in apoptosis. J Cancer Prev. 2016;21(1):13.

    PubMed  PubMed Central  Google Scholar 

  54. Khan F, Ahmed F, Pushparaj PN, Abuzenadah A, Kumosani T, Barbour E, et al. Ajwa date (Phoenix dactylifera L.) extract inhibits human breast adenocarcinoma (MCF7) cells in vitro by inducing apoptosis and cell cycle arrest. PLoS One. 2016;11(7):e0158963.

    PubMed  PubMed Central  Google Scholar 

  55. Delierneux C, Kouba S, Shanmughapriya S, Potier-Cartereau M, Trebak M, Hempel N. Mitochondrial calcium regulation of redox signaling in cancer. Cells. 2020;9(2):432.

    CAS  PubMed Central  Google Scholar 

  56. Garrido C, Galluzzi L, Brunet M, Puig PE, Didelot C, Kroemer G. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ. 2006;13(9):1423–33.

    CAS  PubMed  Google Scholar 

  57. Westphal D, Dewson G, Czabotar PE, Kluck RM. Molecular biology of Bax and Bak activation and action. Biochim Biophys Acta. 2011;1813(4):521–31.

    CAS  PubMed  Google Scholar 

  58. Chaitanya GV, Alexander JS, Babu PP. PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun Signal. 2010;8(1):1–1.

    Google Scholar 

  59. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495–516.

    CAS  PubMed  PubMed Central  Google Scholar 

  60. Kumar S, Pandey AK. Chemistry and biological activities of flavonoids: an overview. Sci World J. 2013;2013:162750.

    Google Scholar 

  61. Yang K, Lamprecht SA, Liu Y, Shinozaki H, Fan K, Leung D, et al. Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon. Carcinogenesis. 2000;21:1655–60.

    CAS  PubMed  Google Scholar 

  62. di Camillo OG, Duarte AC, Bonadio V, Martinez NP, De Araújo ME, Priviero FB, et al. Review of anticancer mechanisms of isoquercitin. World J Clin Oncol. 2016;7:189–99.

    Google Scholar 

  63. Araújo KC, de MB Costa EM, Pazini F, Valadares MC, de Oliveira V. Bioconversion of quercetin and rutin and the cytotoxicity activities of the transformed products. Food Chem Toxicol. 2013;51:93–6.

    PubMed  Google Scholar 

  64. Hashemzaei M, Delarami Far A, Yari A, Heravi RE, Tabrizian K, Taghdisi SM, et al. Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo. Oncol Rep. 2017;38:819–28.

    CAS  PubMed  PubMed Central  Google Scholar 

  65. Khan MA, Siddiqui S, Ahmad I, Singh R, Mishra DP, Srivastava AN, et al. Phytochemicals from Ajwa dates pulp extract induce apoptosis in human triple-negative breast cancer by inhibiting AKT/mTOR pathway and modulating Bcl-2 family proteins. Sci Rep. 2021;11:10322.

    CAS  PubMed  PubMed Central  Google Scholar 

  66. McIlwain DR, Berger T, Mak TW. Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol. 2013;5(4):a008656.

    PubMed  PubMed Central  Google Scholar 

  67. Fuentes-Prior P, Salvesen GS. The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem J. 2004;384(2):201–32.

    CAS  PubMed  PubMed Central  Google Scholar 

  68. Lavrik IN, Golks A, Krammer PH. Caspases: pharmacological manipulation of cell death. J Clin Invest. 2005;115(10):2665–72.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references


The authors wish to extend their thanks to the In-charge of Cell and Tissue Culture Laboratory, Department of Biochemistry, Era’s Lucknow Medical College and Hospital, Era University, for providing basic infrastructure and cell culture facility. The authors would like to acknowledge the financial support offered by Taif University Researchers Supporting Project number (TURSP-2020/50), Taif University, Taif, Saudi Arabia. The authors also acknowledge Cell Death Research Laboratory, Endocrinology Division, CSIR-CDRI, for western blot and flow cytometry analysis.


Not applicable.

Author information

Authors and Affiliations



MAK conceived the study and experimental design, and procured Ajwa dates; MAK, IA, MAB, AMAA and DPM contributed other reagents. MAK, RS, SS, IA, RA, SU, QZ, AS, AT, IH, ANS and DPM planned the experiments; RS and SS designed the experimental setup and performed the experiments. SS, RA, MAB, AA, and DPM analyzed data and interpreted results and co-wrote, edited and revised the manuscript. QZ, DPM, RA and ANS provide critical inputs, edited and revised the manuscript. All authors reviewed and approved the manuscript.

Authors’ information

MAK is a Chancellor of Era University, Lucknow. SS is an Assistant Professor, Dept. of Biotechnology, Era University, Lucknow, while RA is an Associate Professor, Dept. of Biochemistry, Era’s Lucknow Medical College and Hospital, Era University, Lucknow. MAB and MAA is associated with University of Hafr Al-Batin and Taif University, SA respectively. QZ is associated with Majmaah University, SA; ANS is a Professor at Dept. of Pathology, Era University, Lucknow, while DPM is a  Senior Principal Scientist at Division of Endocrinology, CSIR-CDRI, Lucknow. RS is a PhD student at Division of Endocrinology, CSIR-CDRI, Lucknow, IA is a Young Scientist at Department of Biochemistry KGMU, Lucknow, SU is a PhD student at Dept. of Biotechnology, Era University, Lucknow while AS, AT and IH are PhD students at Dept. of Biochemistry, Era University, Lucknow.

Corresponding authors

Correspondence to Sahabjada Siddiqui or Durga Prasad Mishra.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

Sahabjada Siddiqui is an Editorial Board Member. NO competing interests exist for any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Supplementary Figure S1.

Full-length blots from different gels showing the expression levels of p53, Bax, Bcl2, cleaved Caspase-3, and PARP-1 cleavage. Proteins p53, Bcl2, cleaved Caspase-3 and one of the β-actin proteins were cropped from different parts of the same blot, while Bax, PARP-1 cleavage and other β-actin proteins were cropped from different blots.

Additional file 2: Table S1.

PASS analysis. Table S2. Drug-like character. Table S3. Admet SAR prediction. Table S4. Bioactivity scores. Table S5. Toxicity Risk Assessment.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khan, M.A., Singh, R., Siddiqui, S. et al. Anticancer potential of Phoenix dactylifera L. seed extract in human cancer cells and pro-apoptotic effects mediated through caspase-3 dependent pathway in human breast cancer MDA-MB-231 cells: an in vitro and in silico investigation. BMC Complement Med Ther 22, 68 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Phoenix dactylifera seed extract
  • Phytoconstituents
  • Human breast cancer
  • Cytotoxicity
  • HPLC
  • Molecular docking